Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships

European Journal of Pharmaceutical Sciences

Volumn 7, Issue 4, 1999, Pages 325-330

  Cronin, M T D ^a   Dearden, J C ^a   Moss, G P ^a   Murray Dickson, G ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Human skin; Polydimethylsiloxane; Quantitative structure activity relationships; Quantitative structure permeability relationships; Transdermal drug delivery

Indexed keywords

ORGANIC COMPOUND;

ARTICLE; DRUG PENETRATION; HYDROPHOBICITY; IN VITRO STUDY; MOLECULAR SIZE; PARTITION COEFFICIENT; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REGRESSION ANALYSIS; SKIN ABSORPTION; SKIN PERMEABILITY; THEORY;

CHEMISTRY, PHYSICAL; HUMANS; HYDROGEN BONDING; MOLECULAR WEIGHT; SKIN; SKIN ABSORPTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033038344     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(98)00041-4     Document Type: Article

References (30)

1. Abraham M.H., Chadra H.S., Mitchell R.C. The factors that influence skin penetration of solutes. J. Pharm. Pharmacol. 47:1995;8-16.
2. Barratt M.D. Quantitative structure-activity relationships for permeability. Toxicol. In Vitro. 9:1995;27-37.
3. Charton M., Charton B.I. The structural dependence of amino acid hydrophobicity parameters. J. Theoret. Biol. 99:1982;619-624.
4. Charton, M., Motoc, I. (Eds.), 1983. Steric Effects in Drug Design. Springer-Verlag, Berlin.
5. Cronin M.T.D., Dearden J.C., Gupta R., Moss G.P. An investigation of the mechanism of flux across polydimethylsiloxane membranes by quantitative structure-permeability relationships. J. Pharm. Pharmacol. 50:1998;143-152.
6. Dearden J.C. Partitioning and lipophilicity in quantitative structure-activity relationships. Environ. Health Persp. 61:1985;203-228.
7. Dearden, J.C., Bradburne, S.J.A., Cronin, M.T.D., Solanki, P., 1988. The physical significance of molecular connectivity. In: Turner, J.E., England, M.W., Schultz, T.W., Kwaak, N.J. (Eds.), Proceedings of the Third International Workshop on Quantitative Structure-Activity Relationships in Environmental Toxicology. US Department of Energy, Oak Ridge, TN, pp. 43-50.
8. Dewar M.J.S., Zoebisch E.G., Healy E.F., Stewart J.J.P. The development and use of quantum-mechanical models. 76. AM1 - A new general-purpose quantum-mechanical molecular model. J. Am. Chem. Soc. 107:1985;3902-3909.
9. Flynn, G.L., 1990. Physicochemical determinants of skin absorption. In: Gerrity, T.R., Henry, C.J. (Eds.), Principle of Route-to-Route Extrapolation for Risk Assessment. Elsevier, New York, pp. 93-127.
10. Friend D.R. In vitro skin permeation techniques. J. Cont. Rel. 18:1992;235-248.
11. Fujita T., Nishioka T., Nakajima M. Hydrogen-bonding parameter and its significance in quantitative structure-activity studies. J. Med. Chem. 20:1977;1071-1081.
12. Garrett E.R., Chemburkar P.B. Evaluation, control and prediction of drug diffusion through polymeric membranes II. J. Pharm. Sci. 57:1968;949-959.
13. Hansch, C., Leo, A., 1979. Substituent Constants for Correlation Analysis in Chemistry and Biology. Wiley, New York.
14. Idson, B., Charanjit, R.B., 1987. Drug structure vs. penetration. In: Kydonieus, A.F., Berner, B. (Eds.), Transdermal Delivery of Drugs, Vol. III. CRC Press, Boca Raton, FL, pp. 85-151.
15. Johnson M.E., Blankschtein D., Langer R. Permeation of steroids through human skin. J. Pharm. Sci. 84:1995;1144-1146.
16. Kier, L.B., Hall, L.H., 1986. Molecular Connectivity in Structure-Activity Analysis. Research Studies Press, Wiley, Chichester.
17. Kirchner L.A., Moody R.P., Doyle E., Bose B., Jeffry J., Chu I. The prediction of skin permeability by using physicochemical data. ATLA. 25:1997;359-370.
18. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23:1997;3-25.
19. McCafferty D.F., Woolfson A.D., McClelland K.H., Boston V. Comparative in vivo and in vitro assessment of percutaneous absorption of local anaesthetics. Br. J. Anaesth. 60:1988;64-69.
20. Magrab N.A., Williams A.C., Barry B.W. Estradiol permeation through human skin and silastic membrane - effects of propylene glycol and supersaturation. J. Control. Release. 36:1995;277-294.
21. Potts R.O., Guy R.H. Predicting skin permeability. Pharm. Res. 9:1992;663-669.
22. Potts R.O., Guy R.H. A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm. Res. 12:1995;1628-1633.
23. Pugh W.J., Hadgraft J. Ab initio prediction of human skin permeability coefficients. Int. J. Pharm. 103:1994;163-178.
24. Pugh W.J., Roberts M.S., Hadgraft J. Epidermal permeability - penetrant structure relationships: 3. The effect of hydrogen bonding interactions and molecular size on diffusion across the stratum corneum. Int. J. Pharm. 138:1996;149-165.
25. Scheuplein R.J., Blank I.H. Permeability of the skin. Physiol. Rev. 51:1971;702-747.
26. Scheuplein R.J., Blank I.H., Brauner G.J., Macfarlane D.J. Percutaneous absorption of steroids. J. Invest. Dermatol. 52:1969;63-70.
27. van de Waterbeemd H., Camenisch G., Folkers G., Raevsky O.A. Estimation of Caco-2 cell permeability using calculated molecular descriptors. Quant. Struct.-Act. Relat. 15:1996;480-490.
28. Wittiker C., Walker J.D., Gay D.A., Neal M.W. OSHA chemical referred to the ISCA Interagency Testing Committee for percutaneous absorption testing and prioritization and analysis of OSHA skin notation criteria. Toxicologist. 13:1993;101.
29. Woolfson A.D., McCafferty D.F. Percutaneous local anaesthesia: drug release characteristics of the amethocaine phase-change system. Int. J. Pharm. 94:1993;75-80.
30. Yang G., Lien E.J., Gao Z. Physical factors contributing to hydrophobic constant π Quant. Struct.-Act. Relat. 5:1986;12-18.